307 related articles for article (PubMed ID: 19031027)
1. Aspirin and the induction of tolerance by dendritic cells.
Buckland M; Lombardi G
Handb Exp Pharmacol; 2009; (188):197-213. PubMed ID: 19031027
[TBL] [Abstract][Full Text] [Related]
2. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
Adorini L; Penna G
Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
[TBL] [Abstract][Full Text] [Related]
3. Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.
van Kooten C; Stax AS; Woltman AM; Gelderman KA
Handb Exp Pharmacol; 2009; (188):233-49. PubMed ID: 19031029
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-treated human DCs up-regulate ILT-3 and induce hyporesponsiveness and regulatory activity in responder T cells.
Buckland M; Jago CB; Fazekasova H; Scott K; Tan PH; George AJ; Lechler R; Lombardi G
Am J Transplant; 2006 Sep; 6(9):2046-59. PubMed ID: 16869801
[TBL] [Abstract][Full Text] [Related]
5. Use of rapamycin in the induction of tolerogenic dendritic cells.
Fischer R; Turnquist HR; Taner T; Thomson AW
Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
[TBL] [Abstract][Full Text] [Related]
6. Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation.
Chorny A; Gonzalez-Rey E; Delgado M
Ann N Y Acad Sci; 2006 Nov; 1088():187-94. PubMed ID: 17192565
[TBL] [Abstract][Full Text] [Related]
7. Programmed death ligand 1 (PD-L1) plays a vital part in DC tolerogenicity induced by IFN-γ.
Švajger U; Tešić N; Rožman P
Int Immunopharmacol; 2021 Oct; 99():107978. PubMed ID: 34298399
[TBL] [Abstract][Full Text] [Related]
8. Induction of CD4+ CD25+ Foxp3+ T regulatory cells by dendritic cells derived from ILT3 lentivirus-transduced human CD34+ cells.
Ge G; Tian P; Liu H; Zheng J; Fan X; Ding C; Jin Z; Luo X; Xue W
Transpl Immunol; 2012 Jan; 26(1):19-26. PubMed ID: 22005288
[TBL] [Abstract][Full Text] [Related]
9. Aspirin modified dendritic cells are potent inducers of allo-specific regulatory T-cells.
Buckland M; Jago C; Fazekesova H; George A; Lechler R; Lombardi G
Int Immunopharmacol; 2006 Dec; 6(13-14):1895-901. PubMed ID: 17219690
[TBL] [Abstract][Full Text] [Related]
10. [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients].
Han CH; Li HF; Wang YX; Zhang M; Wang Y; Yin M; Min ZL; Zheng KL
Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1327-32. PubMed ID: 16029632
[TBL] [Abstract][Full Text] [Related]
11. Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4.
Svajger U; Vidmar A; Jeras M
Int Immunopharmacol; 2008 Jul; 8(7):997-1005. PubMed ID: 18486911
[TBL] [Abstract][Full Text] [Related]
12. Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function.
Dahlqvist G; Renaud S; Barjon C; Lefebvre A; Aoudjehane L; Horsmans Y; Delhem N; Conti F
Immunobiology; 2021 Jan; 226(1):152031. PubMed ID: 33278711
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Dual-Sized Microparticle System Conditions Human Antigen Presenting Cells Into a Tolerogenic Phenotype
Brusko MA; Stewart JM; Posgai AL; Wasserfall CH; Atkinson MA; Brusko TM; Keselowsky BG
Front Immunol; 2020; 11():574447. PubMed ID: 33193362
[TBL] [Abstract][Full Text] [Related]
16. Tolerogenic dendritic cells suppress murine corneal allograft rejection by modulating CD28/CTLA-4 expression on regulatory T cells.
Yan F; Cai L; Hui Y; Chen S; Meng H; Huang Z
Cell Biol Int; 2014 Jul; 38(7):835-48. PubMed ID: 24604878
[TBL] [Abstract][Full Text] [Related]
17. Tolerogenic dendritic cells generated
Dao Nyesiga G; Pool L; Englezou PC; Hylander T; Ohlsson L; Appelgren D; Sundstedt A; Tillerkvist K; Romedahl HR; Wigren M
Front Immunol; 2023; 14():1045183. PubMed ID: 37901231
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of clinical grade human tolerogenic dendritic cells.
Naranjo-Gómez M; Raïch-Regué D; Oñate C; Grau-López L; Ramo-Tello C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE
J Transl Med; 2011 Jun; 9():89. PubMed ID: 21658226
[TBL] [Abstract][Full Text] [Related]
19. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
Schülke S
Front Immunol; 2018; 9():455. PubMed ID: 29616018
[TBL] [Abstract][Full Text] [Related]
20. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.
Penna G; Adorini L
J Immunol; 2000 Mar; 164(5):2405-11. PubMed ID: 10679076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
